CA Bill would punish Doctors over COVID ‘Misinformation,’ as other states move to protect Doctors’ rights
By David Charbonneau, Ph.D. | The Defender | February 23, 2022
Before the U.S. Supreme Court last month blocked the Biden administration’s COVID-19 vaccine mandates for large employers and allowed the mandate for healthcare workers to stand, all eyes were on the feds when it came to COVID-related policies.
But state lawmakers also have been busy drafting bills in an effort to shape COVID policies closer to home.
The California Assembly, for example, introduced over the past six months a flurry of bills designed to strengthen vaccination mandates and regulate treatment options for patients.
For example, Sen. Richard Pan (D-Sacramento) last month introduced legislation proposing COVID vaccine mandates for all K-12 students in California schools.
And this month, Assembly Member Evan Low (D-Campbell) introduced legislation (AB 2098) that, according to the Los Angeles Times, would “make it easier for the Medical Board of California to discipline doctors who promote COVID-19 misinformation by classifying it as unprofessional conduct.”
The bill defines “unprofessional conduct” as any action a physician or surgeon takes “to disseminate or promote misinformation or disinformation related to COVID-19, including false or misleading information regarding the nature and risks of the virus, its prevention and treatment; and the development, safety, and effectiveness of COVID-19 vaccines.”
Under the bill, disciplinary action could be brought against a physician for disseminating information that “resulted in an individual declining opportunities for COVID-19 treatment or prevention that was not justified by the individual’s medical history or condition.”
Additionally, doctors could be disciplined for “misinformation or disinformation” that is contradicted by contemporary scientific consensus to an extent where its dissemination constitutes gross negligence” by the physician.
Commenting on the criteria, Dr. Meryl Nass, an expert in epidemiology and vaccine injury and member of the Children’s Health Defense scientific advisory committee, said:
“I think this is clearly an attempt to legislate that the government of California or the Medical Board of California will define what is truth and what is misinformation, and medical providers will have to follow lockstep with that definition.
“This, of course, is the same thing as the Ministry of Truth in George Orwell’s “1984,” and if the California legislature actually votes for this bill, the intent of the action will be to enforce a one and only truth.
“Nowhere does this legislature define what is misinformation and disinformation. They do talk about contemporary scientific consensus but as we know in the last two years, the so-called scientific consensus — or the public health agency consensus — on masks, on vaccination, on boosters, etc. has flip-flopped all over the place. So we have adequate examples that the concept of “contemporary scientific consensus” is basically meaningless in this context.”
Contrary to typical board practice, under AB 2098, physicians could also be disciplined for public speech, including social media posts, unrelated to the actual treatment of patients.
Supporters of Low’s bill insist the legislation does not impinge on doctors’ freedom of speech.
“This isn’t a call for a policing of free speech,” Nick Sawyer, an emergency room doctor who founded a group called No License for Disinformation, told the LA Times. “This is a call for protecting the public against dangerous misinformation, which patients are parroting back to us in our emergency room departments every day.”
Nass disagreed:
“The result is removing options from doctors and patients. And the longer-term consequence is that doctors will become irrelevant if they are not needed to assess each individual’s personal risks and benefits from each type of medical care.
“The government and its partners in the healthcare industries can simply prescribe one-size-fits-all healthcare for everyone.”
Low’s bill, introduced as part of a larger effort by a group of Democratic state legislators to strengthen vaccination laws, set off a contentious debate over how far the state should go in pursuing COVID mandates.
Other COVID-related bills introduced in California include:
- Assembly Bill 1993, authored by Buffy Wicks (D-Oakland), would require employees and independent contractors to be vaccinated against COVID as a condition of employment unless they have an exemption based on a medical condition, disability or religious beliefs.
- Assembly Bill 1797, introduced by Akilah Weber (D-San Diego), allows California school officials to more easily check student vaccine records by expanding access to a statewide immunization database.
- Senate Bill 866, introduced by Sen. Scott Wiener (D-San Francisco) would let children 12 and older be vaccinated without parental consent.
Other states pursue efforts to support alternative treatments
In contrast to California, several state legislatures are moving to provide legal support for off-label prescriptions and alternative approaches supported by physicians.
In New Hampshire, legislators last month held public hearings on a bill that would allow for over-the-counter dissemination of ivermectin at pharmacies, provided certain treatment plan requirements were met.
New Hampshire HB 1022 would permit pharmacists to dispense the ivermectin by means of a standing order entered into by licensed healthcare professionals.
Sponsors of the bill argued many healthcare workers are unable to prescribe ivermectin, either because of hospital politics or outside professional pressures.
The bill has support from Dr. Paul Marik, who traveled from Virginia to testify at the public hearing.
A former professor of medicine and chief of pulmonary and critical care medicine at Eastern Virginia Medical School, Marik sued the hospital he worked for after it banned physicians from prescribing ivermectin for COVID patients.
Marik resigned late last year in protest of the ban.
During his testimony in New Hampshire, Marik described ivermectin as “cheap, exceedingly safe and exceedingly effective.”
“If ivermectin had been promoted at the beginning of this pandemic, we would not be sitting here today,” Marik said.
Kansas lawmakers last month advanced a bill supporting the prescribing of ivermectin and hydroxychloroquine. The model legislation, also introduced in Tennessee, would require pharmacists to fill prescriptions for the off-label use of ivermectin and hydroxychloroquine.
In direct contrast to the California legislation, the Kansas bill also would mandate that doctors not be subject to disciplinary action for any “recommendation, prescription, use or opinion … related to a treatment for COVID-19, including a treatment that is not recommended or regulated by the licensing board,” Kansas Department of Health and Environment or the U.S. Food and Drug Administration.
“Such actions,” the bill states, “could not be considered unprofessional conduct.”
Kansas lawmaker Sen. Mark Steffen (R-Hutchinson) supports the bill. Steffen, an anesthesiologist, said he’s under investigation by the University of Kansas Health System with which he is affiliated for prescribing ivermectin to COVID patients.
Dr. Festus Krebs III, a physician representing the Catholic Medical Association of Kansas City, also spoke in favor of the bill:
“With ivermectin and hydroxychloroquine, we now have 76 ivermectin COVID-19 controlled studies which show 66 percent overall improvement and 57 percent decreased mortality.”
Meanwhile, in Florida, legislation that would extend protection for hospitals against patient lawsuits over COVID care sits on the desk of Gov. Ron DeSantis, awaiting signature or a veto.
And in New York, the state’s comptroller — citing the investment of the state’s public pension plan in Spotify — sent a letter to the company asking it to increase its screening of “misinformation” on their platform.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
Oklahoma AG declares medical boards can’t punish doctor for prescribing ivermectin
LifeSiteNews | February 16, 2022
OKLAHOMA CITY – Doctors in Oklahoma are well within their professional rights to prescribe ivermectin (IVM) and hydroxychloroquine (HCQ) to COVID-19 patients, state Attorney General John O’Connor affirmed, despite the drugs’ disfavored status within the federal health bureaucracy.
“The Attorney General’s office finds no legal basis for a state medical licensure board to discipline a licensed physician for exercising sound judgment and safely prescribing an FDA-approved drug – like ivermectin or hydroxychloroquine – for the off-label purpose of treating a patient with COVID-19,” O’Connor’s office concluded in a February 8 statement, declaring that “healthcare professionals should have every tool available to combat COVID-19.”
“The Attorney General’s office neither condones nor condemns a specific course of treatment for COVID-19,” the release added. “Our office maintains that proper healthcare decisions are to be made between a patient and his or her physician, and the government should not interfere with their relationship.”
Despite being misrepresented in the mainstream media as aquarium cleaner and horse dewormer, respectively, hydroxychloroquine and ivermectin are both FDA-approved medications with a range of human applications, such that both are listed on the World Health Organization’s Model List of Essential Medicines. Like many medications, ivermectin is also used for horses, but human dosages of the drug for human ailments were not controversial until IVM started gaining notice in the context of COVID-19.
While experts continue to debate the drugs’ effectiveness at treating COVID-19, promising studies as well as reports of positive results have generated significant interest in them, as has the fact that they have been used and studied for far longer than the COVID-19 vaccines, which were developed and released in record time by the Trump administration’s Operation Warp Speed initiative. Many believe the long-established drugs are safer than relatively new vaccines they believe have been rushed and politicized.
Despite the established safety of IVM and HCQ, and the evolving nature of COVID knowledge, families across the country have had to go to court to force hospitals to let them try the drugs for their loved ones, while doctors have seen their medical licenses threatened for prescribing them – a scenario the Oklahoma Attorney General’s Office indicates will not be tolerated in the Sooner State.
The University of Minnesota, Emory University School of Medicine, Northwestern Medicine, and other medical institutions are currently conducting a major at-home clinical trial to assess ivermectin’s effectiveness at treating COVID-19, as well as that of the drugs metformin and fluvoxamine or any combination of the three.
Nebraska AG Says Doctors Can Legally Prescribe Ivermectin, HCQ for COVID, Calls Out FDA, CDC, Fauci, Media for ‘Fueling Confusion and Misinformation’
By Megan Redshaw | The Defender | October 18, 2021
Few subjects have been more controversial than ivermectin and hydroxychloroquine — two long-established, inexpensive medications widely and successfully used in many parts of the world for the prevention and treatment of COVID.
By contrast, the use of both medications against COVID has been largely suppressed in the U.S, where doctors have been threatened and punished for prescribing them.
On Oct. 15, Nebraska Attorney General (AG) Doug Peterson issued a legal opinion that Nebraska healthcare providers can legally prescribe off-label medications like ivermectin and hydroxychloroquine for the treatment of COVID, so long as they obtain informed consent from the patient.
However, if they did neglect to obtain consent, deceive, prescribe excessively high doses or other misconduct, they could be subject to discipline, Peterson wrote.
The AG’s office emphasized it was not recommending any specific treatment for COVID. “That is not our role,” Peterson wrote. “Rather, we address only the off-label early treatment options discussed in this opinion and conclude that the available evidence suggests they might work for some people.”
Peterson said allowing physicians to consider early treatments will free them to evaluate additional tools that could save lives, keep patients out of the hospital and provide relief for our already strained healthcare system.
The opinion, based on an assessment of relevant scientific literature, was rendered in response to a request by Dannette Smith, CEO of the Nebraska Department of Health and Human Services.
Smith asked the AG’s office to look into whether doctors could face discipline or legal action under Nebraska’s Uniform Credential Act (UCA) — meant to protect public health, safety and welfare — if they prescribed ivermectin or hydroxychloroquine.
“After receiving your question and conducting our investigation, we have found significant controversy and suspect information about potential COVID-19 treatments,” Peterson wrote.
For example, a paper published in the Lancet — one of the most prestigious medical journals in the world — denounced hydroxychloroquine as dangerous, yet the statistics were flawed and the authors refused to provide analyzed data.
The paper was retracted, but not before countries stopped using the drug and trials were cancelled or interrupted.
“The Lancet’s own editor-in-chief admitted that the paper was a ‘fabrication,’ a ‘monumental fraud’ and a ‘shocking example of research misconduct’ in the middle of a global health emergency,” Peterson wrote in the opinion.
A recently published paper on COVID recognized that “for reasons that are yet to be clarified,” early treatment has not been emphasized despite numerous U.S. healthcare providers advocating for early treatment and “scores of treating and academic physicians” — who have published papers in well respected journals — urging early interventions.
Peterson cited numerous studies showing ivermectin and hydroxychloroquine reduced mortality by up to 75% or more when used as a preventative or prophylaxis for COVID, suggesting hundreds of thousands of lives could have been saved had the drugs been widely used in America.
“Every citizen — Democrat or Republican — should be grateful for Doug Peterson’s thoughtful and courageous counteroffensive against the efforts of Big Pharma, its captive federal regulators, and its media and social media allies to silence doctors and deny Americans life-saving treatments,” Robert F. Kennedy Jr., chairman of Children’s Health Defense, told The Defender via email.
“We finally have a leader who puts constitutional rights, peer-reviewed science and human health above industry profits. Doug Peterson is uncowed and unbowed — a genuine hero on horseback for all Americans.” Kennedy said.
Children’s Health Defense President Mary Holland agreed. “This Nebraska AG opinion lets doctors get back to being doctors — without being second-guessed by government, pharmacists and others interfering in the crucial doctor-patient relationship,” Holland said.
Although the AG’s office did not rule out the possibility that other off-label drugs might show promise — either now or in the future — as a prophylaxis or treatment against COVID, it confined its opinion to ivermectin and hydroxychloroquine for the sake of brevity.
Nebraska AG highlights science on ivermectin
In his legal opinion, Peterson concluded evidence showed ivermectin demonstrated striking effectiveness in preventing and treating COVID, and any side effects were primarily minor and transient. “Thus, the UCA does not preclude physicians from considering ivermectin for the prevention or treatment of COVID,” Peterson wrote.
In the decade leading up to the COVID pandemic, Peterson found numerous studies showing ivermectin’s antiviral activity against several RNA viruses by blocking the nuclear trafficking of viral proteins, adding to 50 years of research confirming ivermectin’s antiviral effects.
In addition, safety data for ivermectin showed side effects were “vanishingly small.” The latest statistics available through VigiAccess reported only 5,674 adverse drug reactions to ivermectin between 1992 and October 13, 2021, an “incredibly low” number given that 3.7 billion doses have been administered since the 1980s, Peterson wrote.
Peterson cited several studies showing ivermectin led to improvement of COVID outcomes when used in early treatment or as a prophylaxis, while noting many studies with negative findings about ivermectin “excluded most available evidence,” cherry picked data within studies, misreported data, made unsupported assertions of adverse reactions to ivermectin and had “conclusions that did follow from evidence.”
Peterson also found that epidemiological evidence for ivermectin’s effectiveness, derived by analyzing COVID-related data from various states, countries or regions is instructive in the context of a global pandemic.
In one instance, a group of scholars analyzed data comparing COVID rates of countries that routinely administer ivermectin as a prophylaxis and countries that did not. The research showed “countries with routine mass drug administration of prophylactic … ivermectin have a significantly lower incidence of COVID-19.”
“This ‘highly significant’ correlation manifests itself not only ‘in a worldwide context’ but also when comparing African countries that regularly administer prophylactic ‘ivermectin against parasitic infections’ and African countries that do not,” Peterson wrote. “Based on these results, the researchers surmised that these results may be connected to ivermectin’s ability to inhibit SARS-CoV-2 replication, which likely leads to lower infection rates.”
Nebraska AG calls out FDA, Fauci on hypocrisy on ivermectin
Many U.S. health agencies have now addressed the use of ivermectin for COVID. The National Institutes of Health (NIH) has adopted a neutral position, choosing not to recommend for or against the use of ivermectin — a change from its position in January 2021 where it discouraged use of the drug for treatment of COVID.
Peterson wrote:
“The reason for the change is the NIH recognized several randomized trials and retrospective cohort studies of ivermectin use in patients with COVID-19 have been published in peer-reviewed journals. And some of those studies reported positive outcomes, including shorter time to resolution of disease manifestations that were attributed to COVID-19, greater reduction in inflammatory marker levels, shorter time to viral clearance, [and] lower mortality rates in patients who received ivermectin than in patients who received comparator drugs or placebo.”
Yet, on Aug. 29, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases within the NIH, went on CNN and announced “there is no clinical evidence” that ivermectin works for the prevention or treatment of COVID. Fauci went on to reiterate that “there is no evidence whatsoever” that it works.
“This definitive claim directly contradicts the NIH’s recognition that ‘several randomized trials … published in peer-reviewed journals’ have reported data indicating that ivermectin is effective as a COVI D-19 treatment,” Peterson wrote.
In March 2021, the FDA posted a webpage, “Why You Should Not Use lvermectin to Treat or Prevent COVID-19.”
“Although the FDA’s concern was stories of some people using the animal form of ivermectin or excessive doses of the human form, the title broadly condemned any use of ivermectin in connection with COVID-19,” Peterson wrote. “Yet, there was no basis for its sweeping condemnation.”
Peterson wrote:
“Indeed, the FDA itself acknowledged on that very webpage (and continued to do so until the page changed on September 3, 2021) that the agency had not even ‘reviewed data to support use of ivermectin in COVID-19 patients to treat or to prevent COVID-19.’ But without reviewing the available data, which had long since been available and accumulating, it is unclear what basis the FDA had for denouncing ivermectin as a treatment or prophylaxis for COVID-19.
“On that same webpage, the FDA also declared that ‘[i]vermectin is not an anti-viral (a drug for treating viruses).’ It did so while another one of its webpages simultaneously cited a study in Antiviral Research that identified ivermectin as a medicine ‘previously shown to have broad-spectrum anti-viral activity.’”
“It is telling that the FDA deleted the line about ivermectin not being ‘anti-viral’ when it amended the first webpage on September 3, 2021,” Peterson noted.
Peterson said the FDA’s most controversial statement on ivermectin was made on Aug. 21, when it posted a link on Twitter to its “Why You Should Not Use lvermectin” webpage with this statement: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”
“This message is troubling not only because it makes light of a serious matter but also because it inaccurately implies that ivermectin is only for horses or cows,” Peterson wrote.
Peterson said the FDA has assailed ivermectin’s safety while ignoring the fact that physicians routinely prescribe medications for off-label use and that ivermectin is a “particularly well-tolerated medicine with an established safety record.”
Peterson added the FDA is ignoring several randomized controlled trials and at least one metaanalysis suggesting ivermectin is effective against COVID. He pointed out the Centers of Disease Control and Prevention has adopted a similar stance — unsupported by scientific evidence — and the media has fueled confusion and misinformation on the drug.
Peterson questions professional associations’ stance on ivermectin
Professional associations in the U.S. and internationally have adopted conflicting positions on ivermectin and COVID. The American Medical Association (AMA), American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP) issued a statement in September strongly opposing the ordering, prescribing or dispensing of ivermectin to prevent or treat COVID outside of a clinical trial.
But their statement relied solely on the FDA’s and CDC’s suspect positions.
The AMA, APhA and ASHP also mentioned a statement by Merck — the original patent-holder — opposing the use of ivermectin for COVID because of a “concerning lack of safety data in the majority of studies.”
“But Merck, of all sources, knows that ivermectin is exceedingly safe, so the absence of safety data in recent studies should not be concerning to the company,” Peterson wrote.
Peterson called into question the objectivity of Merck in providing an opinion on ivermectin that U.S. health agencies are relying upon. “Why would ivermectin’s original patent holder go out of its way to question this medicine by creating the impression that it might not be safe?” Peterson asked. “There are at least two plausible reasons.”
Peterson explained:
“First, ivermectin is no longer under patent, so Merck does not profit from it anymore. That likely explains why Merck declined to ‘conduct clinical trials’ on ivermectin and COVID-19 when given the chance.
“Second, Merck has a significant financial interest in the medical profession rejecting ivermectin as an early treatment for COVID-19. [T]he U.S. government has agreed to pay [Merck] about $1.2 billion for 1.7 million courses of its experimental COVID-19 treatment, if it is proven to work in an ongoing large trial and authorized by U.S. regulators.”
Merck’s treatment is known as “molnupiravir,” and aims to stop COVID from progressing when given early in the course of disease. When Merck announced Oct. 1, that preliminary studies indicated molnupiravir reduced hospitalizations and deaths by half, the drug maker’s stock price immediately jumped to 12.3%.
“Thus, if low-cost ivermectin works better than, or even the same as molnupiravir, that could cost Merck billions of dollars,” Peterson wrote.
Peterson takes on science of hydroxychloroquine
Peterson said based on his review of the evidence, his office did not find clear and convincing evidence that would warrant disciplining physicians who prescribe hydroxychloroquine for the prevention or early treatment of COVID after first obtaining informed patient consent.
Peterson pointed to similar findings with hydroxychloroquine — a less toxic derivative of a medicine named chloroquine — widely used since it was approved by the FDA in 1955 for treatment of malaria.
Peterson noted that as early as 2004, a lab study revealed chloroquine was “an effective inhibitor of the replication of the severe acute respiratory syndrome coronavirus (SARS-CoV) in vitro” and should “be considered for immediate use in the prevention and treatment of SARS-CoV infections.”
In 2005, another study showed chloroquine had strong antiviral effects on SARS-CoV infection and was effective in preventing the spread of SARS-CoV in cell cultures.
Other studies showed hydroxychloroquine exhibited antiviral properties that can inhibit SARS-CoV-2 virus entry, transmission and replication, and contains anti-inflammatory properties that help regulate pro-inflammatory cytokines.
Peterson wrote, “many large observational studies suggest that hydroxychloroquine significantly reduces the risk of hospitalization and death when administered to particularly high-risk outpatients as part of early COVID-19 treatment.”
Peterson said the drug is considered to be so safe it can be prescribed for pregnant women, yet during the pandemic, the FDA raised questions about hydroxychloroquine and adverse cardiac events.
These concerns prompted one group of researchers to conduct a systematic review of the hydroxychloroquine safety literature pre-COVID. Their review indicated people taking hydroxychloroquine in appropriate doses “are at very low risk of experiencing cardiac [adverse events], particularly with short-term administration” of the drug.
Researchers noted COVID itself can cause cardiac problems, and there was no reason “to think the medication itself had changed after 70 years of widespread use,” Peterson wrote.
Peterson said one piece of key flawed data had substantially contributed to safety concerns surrounding the drug — the admittedly fraudulent Lancet study that falsely claimed hydroxychloroquine increased frequency of ventricular arrhythmias when used for treatment of COVID.
The findings were so startling that major drug trials involving hydroxychloroquine “were immediately halted” and the World Health Organization pressured countries like Indonesia that were widely using hydroxychloroquine to ban it. Some countries, including France, Italy and Belgium, stopped using it for COVID altogether.
Peterson wrote:
“The problem, however, is that the study was based on false data from a company named Surgisphere, whose founder and CEO Sapan Desai was a co-author on the published paper.
“The data were so obviously flawed that journalists and outside researchers began raising concerns within days of the paper’s publication. Even the Lancet’s editor in chief, Dr. Richard Horton, admitted that the paper was a fabrication, a monumental fraud and a shocking example of research misconduct in the middle of a global health emergency.”
Despite calls for the Lancet to provide a full expansion of what happened, the publication declined to provide details for the retraction.
As with ivermectin, the FDA and NIH adopted positions against the use of hydroxychloroquine for COVID — making assertions that were unsupported by data. The AMA, APhA and ASHP, which opposed ivermectin, also resisted hydroxychloroquine for the treatment of COVID.
By contrast, the Association of American Physicians and Surgeons, and other physician groups, support the use of both ivermectin and hydroxychloroquine as an early treatment option for COVID. Peterson cited an article co-authored by more than 50 doctors in Reviews in Cardiovascular Medicine who advocated an early treatment protocol that includes hydroxychloroquine as a key component.
Governing law allows physicians to prescribe ivermectin and hydroxychloroquine, AG says
Neb. Rev. Stat. § 38-179 generally defines unprofessional conduct as a “departure from or failure to conform to the standards of acceptable and prevailing practice of a profession or the ethics of the profession, regardless of whether a person, consumer or entity is injured, or conduct that is likely to deceive or defraud the public or is detrimental to the public interest.”
The regulation governing physicians states that unprofessional conduct includes:
“[c]onduct or practice outside the normal standard of care in the State of Nebraska which is or might be harmful or dangerous to the health of the patient or the public, not to include a single act of ordinary negligence.”
Peterson said healthcare providers do not violate the standard of care when they choose between two reasonable approaches to medicine.
“Regulations also indicate that physicians may utilize reasonable investigative or unproven therapies that reflect a reasonable approach to medicine so long as physicians obtain written informed patient consent,” Peterson wrote.
“Informed consent concerns a doctor’s duty to inform his or her patient, and it includes telling patients about the nature of the pertinent ailment or condition, the risks of the proposed treatment or procedure and the risks of any alternative methods of treatment, including the risks of failing to undergo any treatment at all.”
Peterson said this applies to prescribing medicine for purposes other than uses approved by the FDA, and that doing so falls within the standard of care repeatedly recognized by the courts.
Peterson said the U.S. Supreme Court has also affirmed that “off-label usage of medical devices” is an “accepted and necessary” practice, and the FDA has held the position for decades that “a physician may prescribe [a drug] for uses or in treatment regimens or patient populations that are not included in approved labeling.”
Peterson said the FDA has stated “healthcare providers generally may prescribe [a] drug for an unapproved use when they judge that it is medically appropriate for their patient, and nothing in the federal Food, Drug and Cosmetic Act (“FDCA”) limit[s] the manner in which a physician may use an approved drug.”
In a statement to KETV NewsWatch 7, Nebraska’s Department of Health and Human Services said:
“The Department of Health and Human Services appreciates the AG’s office delivering an opinion on this matter. The document is posted and available to medical providers as they determine appropriate course of treatment for their patients.”
© 2021 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
Covid Medical insanity, as described by an MD
By Matt Bettag, MD | August 6, 2021
When did the world become insane? What is the reason for it? Big Brother? Depopulation? Or people in love with control?
I don’t know and it’s driving me nuts. But I’ve decided I’m tired of complaining about it to my friends and family and I’m willing to put my name on the line. If the woke culture wants to ruin me for speaking the truth, I guess I might as well just get it over with now.
I have been a physician for 24 years, a practicing ENT for 19 years. I have never before seen the medical establishment just stop thinking. Insanity is the new rule, and common sense cannot even be discussed.
From the beginning, 15 days to “flatten the curve,” I was shocked. We had never done this before, but perhaps this virus was really bad, so I gave the government the benefit of the doubt.
Then came Fauci.
He initially said social distancing didn’t work, and masks were largely ineffective.
But by late March, he pronounced both masking and social distancing necessary. Weird… red flag.
What? So now I am alarmed.
I started researching the utility of masks. There were very good articles I found — one out of a respiratory center in Chicago, and another a good dental review. I bookmarked both of them. Less than a month later, the dental website was down, replaced by a text saying basically that their information is now irrelevant because of COVID. The Chicago article also had a disclaimer that previously wasn’t there saying people shouldn’t use their article politically. What? Don’t use a scientifically derived article to make a scientifically based decision on the utility of masks? What the hell is going on?
Next comes PCR testing. Let’s conveniently jack up the PCR Magnification cycles to 40+, resulting in a 90–97% false positive rate.
Then, let’s start testing all elective surgery, asymptomatic exposures, and hospitalized patients with this fake test to artificially increase the Covid numbers.
In addition we will reimburse hospitals greatly for any diagnosed COVID admissions and ICU visits.
Oxygen doesn’t work; go home until you get worse. Oh, and bring your family and friends with you; they’ll need testing.
Steroids were advised against early on, which made no sense, because they do decrease inflammation and in ENT have been used widely for viral illness.
Next we find a few weeks later the secret drug to treat COVID: steroids. What?
Hydroxychloroquine HCQ—suddenly not safe, even though it has been used for decades worldwide with a great safety profile, but not anymore. Mention it, and you are a lunatic.
The same went for all other proven therapeutics, such as ivermectin and vitamin D.
Vaccines? “I wouldn’t trust anything president Trump made.” That was Kamala Harris back in the fall.
Now if you don’t get vaccinated, you don’t care about other people, and you wanna watch people die.
Oh, and by the way, we should vaccinate everyone, including those who previously had COVID, pregnant women, and small children.
What about VAERS? That’s the open record report system that the CDC has made almost unnavigable. It’s slowly crept up and showed up to 12,000 deaths coincident with the vaccine. Then dropped to 6,000, only to come back up to 10,000 and now back to 12,000–Just a little glitch from our trustworthy government.
There are reports that the numbers could be ten times or more as high, and perhaps the CDC is misclassifying deaths to hide them. But let’s trust the government; they’ve been so good thus far.
Now the latest lie: “the delta variant, is surging because of the unvaccinated.”
Ignore the data from other countries that have very high vaccine rates but high spiking cases, and ignore the data from other countries that have low vaccine rates and almost no COVID.
As a matter fact, let’s not even look at Sweden, who essentially didn’t do lockdowns or masking, has a low vaccination rate, and has almost zero COVID.
I have never lived in the world like this, where open medical dialogue is completely suppressed and there is only one party line.
I thought the left was always talking about how we shouldn’t bully people, and we need to have “dialogue.” Well… let’s start.
The media and the government need to do their job and start opening dialogue to the other side. If we are crazy, it will come out.
If we are right, and the data show that to be the fact, then a large apology is warranted.
Dr. Stella Immanuel sues CNN for $100 Million after being vindicated on Hydroxychloroquine
Big League Politics | July 31, 2021
Dr. Stella Immanuel, the pro-hydroxychloroquine doctor who was derided by the fake news media for attempting to save lives near the peak of the COVID-19 pandemic, is striking back against CNN.
Immanuel has launched a $100 million lawsuit against CNN and host Anderson Cooper for what she believes were false and defamatory statements made against her character.
“In an effort to vilify, demonize and embarrass President [Donald] Trump, Cooper and CNN published a series of statements of fact about Dr. Immanuel that injured her reputation and exposed her to public hatred, contempt, ridicule, and financial injury,” the lawsuit stated. It was filed in federal court on July 27.
Immanuel said that she believes Cooper and CNN “effectively caused the deaths of hundreds of thousands whose lives would have been spared if they had been treated early with HCQ.”
Big League Politics has reported on the suppressed science showing that hydroxychloroquine can effectively treat COVID-19:
“A new study has demonstrated that treating COVID-19 with hydroxychloroquine makes patients 84 percent less likely to be hospitalized.
The study is set to be published in the International Journal of Antimicrobial Agents in December. It has determined that “low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”
The doctors came to their conclusions after treating 141 coronavirus patients with hydroxychloroquine for five days. They compared them with a control group of 377 coronavirus patients who did not receive hydroxychloroquine as a treatment. They found that “the odds of hospitalization of treated patients was 84% less than in the untreated patients.” Only one patient from the group treated with hydroxychloroquine died while 13 people died in the other group…
The elites are suppressing hydroxychloroquine because they want the public to feel helpless against the virus. They never intend to give the public their liberties back, hoping that the public will accept a “new normal” of globalism and technocracy.“
A victory for Immanuel in court would be a powerful rebuke to the propaganda machine set up to maximize profits for Big Pharma and demonize whistleblowers who actually want to help patients.
Are the Covid-19 vaccines “safe and effective”?
Steve Kirsch | Trial Site News | June 16, 2021
A video presentation by Steve Kirsch, Executive Director of the Covid-19 Early Treatment Fund.
Watch Video at Trial Site News
Are there any risks associated with the COVID-19 vaccines currently authorized on an emergency use basis by the U.S. Food and Drug Administration (FDA)? Presently three genetic-based vaccines have been authorized via the emergency order including two mRNA-based vaccines (Moderna and Pfizer-BioNTech) as well as the adenovirus-based Johnson and Johnson product. Developed at historical speed under Operation Warp Speed, the mRNA-based technology foretells enormous implications for healthcare including the prospect of vaccines for cancer. An amazing research prowess has unfolded in response to the COVID-19 pandemic heralding profound breakthroughs that’ll benefit society for years to come. Governmental authorities have declared the vaccines both safe and effective and as TrialSite recently reported based on a change of law that waives the need for informed consent with investigational products. Both the U.S. Centers for Disease Control and Prevention (CDC) and FDA have declared that the risk-benefit analyses strongly indicate the risks of not getting a vaccination outweigh any risk of vaccination. They argue that the risks associated with COVID-19 are materially greater. Moreover, health authorities are on record that there is absolutely no correlation associated with the COVID-19 vaccines to any deaths as indicated by the CDC declaration. But have they sufficiently probed and pursued granular investigation into their own data? Have they undertaken the comprehensive analyses associated with what in the CDC VAERS is now close to 6,000 deaths. Are all of these unrelated to the vaccines? Steve Kirsch, the founder and executive director of the COVID-19 Early Treatment Fund (CETF), a regular contributor to the TrialSite recently conducted a more systematic and thorough analysis of the VAERS and CDC adverse event and death numbers reported in conjunction with the COVID-19 vaccines. The results are disturbing to say the least. TrialSite offers no opinion here other than the presentation of the highly successful MIT-trained engineer who has invested millions of his own funds into early stage treatment options targeting COVID-19. What follows is a summary of his deep dive into VAERS presented in this video.
Official CDC Position
The CDC is on the record that the now nearly 6,000 deaths reported in VAERS since December 2020, including “A review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccine.”
The analysis provided by Kirsch suggests that while nearly 6,000 are now entered into the voluntary system, he suggests the actual number could be undercounted by a magnitude of up to 5 times and a review of direct CDC excess death data indicates what the notable entrepreneur counts as 25,000 deaths that could be associated with the coronavirus vaccines.
The Presentation
The Kirsch presentation starts with an introduction to the CDC Vaccine Adverse Event Reporting System known as VAERS with a review of some key indicators including reported deaths. Open to the public, he reveals by June 4th the following adverse events were associated with the COVID-19 vaccines:
Reported Event #s Deaths 5,088 Hospitalizations 19,587 Urgent Care 43,891 Office Visits 58,800 Heart Attacks 2,190 Anaphylaxis 1,459 Bells Palsy 1,737 Thrombocytopenia/Low Platelet 1,564 Myocarditis/Pericarditis 1,087
A review of available clinical information, including death certificates, autopsy, and medical records, has not established a causal link to COVID-19 vaccines.
At 12:15 into the presentation Mr. Kirsch reveals a data distribution revealing a dramatic spike in deaths associated with the COVID-19. Moreover in this data analysis it’s revealed that the majority of deaths occur closer to the actual time of the vaccination event indicating a higher probability of a causal relationship.
At 12:49 he presents the data findings indicating that overwhelming the incidents of heart attacks associated with the VAERS COVID-19 vaccine spike within a day to three days after the vaccination event. He also emphasizes that the indication of Myocarditis/Pericarditis actually increases with vaccination as age decreases which is counter intuitive in that young people should have less probability of experiencing such heart related troubles. Is the vaccine causally connected to this data?
At 15:51 in the presentation Kirsch depicts again the growing numbers of deaths corresponding to the release of the vaccines under emergency use authorization by mid-December 2020. At 18:55 he reveals a corresponding increase in excess deaths reported by the CDC.
Kirsch goes on at 26:13 to discuss the imperative to consider a time out in the process to at least investigate these safety data signals. At 28:09 Kirsch raises the imperative for informed consent under the Declaration of Helsinki. Although as TrialSite reported the law was changed in 2016 thus waiving the need for informed consent with investigational products deemed safe.
At 32:22 Mr. Kirsch discusses early treatment options for COVID-19. He shares that considerable research has gone on pointing to a number of potential treatments for early onset COVID-19 that can serve to help combat COVID-19. A risk-benefit comparison at 41:50 showcases at least one argument that early stage treatments currently under study should be accelerated.
The presenter offers a plethora of other information that merits review for those interested in a debate on this topic.
Kirsch commented on the findings “The narrative is that the COVID-19 vaccines are safe and effective but the truth is that the data points to an otherwise alternative conclusion.” Kirsch declared that “if anyone was paying attention they would have picked up these safety signals by the end of January.”
Data-Driven Truth or Random Coincidence?
TrialSIte cannot advocate one position over another but rather can serve to share information that fits within the guidelines of the platform for purposes of discussion and hopefully healthy debate. This isn’t a platform for attacking others but rather one that fosters awareness, transparency and engagement. The data present in the CDC VAERS database as well as the CDC death reports do indicate a material spike in activity associated with the coronavirus vaccines. Does the CDC’s position that none of these deaths are conclusively correlated to the vaccine itself despite the data in this presentation revealing a disturbing trend of adverse events and death within a day to three days within the vaccination event? It’s not clear but TrialSite invites the CDC and others on to the platform to put forth an explanation.